Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration.
Authors: Popot M A, Bonnaire Y, Guéchot J, Toutain P L
Journal: Equine veterinary journal
Summary
Hyaluronic acid (HA) is an endogenous glycosaminoglycan widely used therapeutically for joint disease in horses, yet its presence in circulation following treatment creates challenges for racing medication control. Popot and colleagues characterised baseline HA physiology and tracked its clearance after intravenous and intra-articular administration by measuring plasma concentrations (via ELISA) and synovial fluid levels (via radiometric binding assay) in post-competition horses and experimental animals. Mean baseline plasma HA in 120 competing horses was 89 ng/ml, whilst synovial fluid concentrations averaged 328 micrograms/ml; critically, intravenous sodium hyaluronate (37.8 mg total dose) demonstrated an extremely short terminal half-life of 43 minutes, with plasma returning to control values within 3 hours, and intra-articular administration showed no significant elevation in joint HA at 24 hours post-injection. The endogenous production rate of 33–164 mg daily far exceeded the recommended intravenous therapeutic dose, meaning administered HA is rapidly absorbed or cleared from both circulation and synovial compartments. These findings have substantial implications for farriers, veterinarians and competition officials: the rapid clearance kinetics suggest that detection windows for HA as a medication are narrow, screening protocols must account for substantial natural variation in baseline values, and practitioners should reconsider dosing frequency if therapeutic persistence rather than acute administration is the clinical objective.
Read the full abstract on PubMed
Practical Takeaways
- •Hyaluronic acid has extremely rapid clearance from systemic circulation (half-life ~45 minutes), making single-dose intravenous administration unlikely to leave detectable residues beyond a few hours post-treatment
- •Horses naturally produce substantial amounts of hyaluronic acid daily (1-4 times therapeutic doses), suggesting endogenous production is a significant physiological process that should inform medication control policies
- •Intra-articular administration results in rapid clearance from the joint within 24 hours, which has implications for the timing of diagnostic sampling in medication control situations and the duration of therapeutic effect
Key Findings
- •Mean plasma hyaluronic acid concentration in 120 post-competition horses was 89 ng/ml
- •Intravenous sodium hyaluronate (37.8 mg) had a terminal half-life of 43±29 minutes with return to baseline within 3 hours
- •Endogenous hyaluronic acid production rate was 33-164 mg/day, equivalent to 1-4 times the recommended intravenous daily therapeutic dose
- •Intra-articular hyaluronate returned to control synovial fluid concentrations (328±112 μg/ml) within 24 hours